FSD Pharma’s New CEO is a Top GW Pharma Executive
November 27, 2018
Ryan Allway November 27th, 2018 News, Top News Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, but the market pales in comparison to the global pharmaceutical industry—which could reach more than $1 trillion by 2020. Cannabis investors shouldn’t ignore the... Read more
Lexaria Targets Cannabinoids, Tobacco, Hemp, and Pharma Markets with New Subsidiaries
November 13, 2018
Ryan Allway November 13th, 2018 Exclusive, News, Top News The cannabis industry is projected to generation hundreds of billions of dollars of revenue over the coming years, driven by the legalization of medical and recreational cannabis across North America. While many investors are focused on cultivation or dispensary... Read more
Ryan Allway November 12th, 2018 News, Top Story Gabriella’s Kitchen (CSE: GABY), the award-winning consumer packaged goods company whose array of super-nutritional foods are currently sold in more than 3,400 stores across North America, is launching a revolutionary new line of cannabis infused nutritional edibles. The expansion as... Read more
CALGARY and SANTA ROSA, CA, Nov. 9, 2018 /CNW/ – Gabriella’s Kitchen Inc. (the “Company” or “GABY”) (CSE: GABY) today provided comments to shareholders on recent changes in United States cannabis regulations, plus other national and international developments in the cannabis sector. GABY commented to shareholders today on recent draft regulations... Read more
CFN Media’s Exclusive Interview with Pascal Biosciences
November 8, 2018
Ryan Allway November 8th, 2018 Exclusive, News, Press Releases, Top Story The cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. While many investors are familiar with... Read more
Pascal Biosciences Announces Optimization of Cannabinoid-Derived Drug Candidates to Kill Glioblastoma Cells
November 5, 2018
Ryan Allway November 5th, 2018 News, Press Releases VANCOUVER, British Columbia and SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the peer reviewed publication and upcoming presentation of their recently licensed cannabinoid-derived drug... Read more
